HIGHLIGHTS
- who: Fasheng Li and colleagues from the Department of Imaging, The Fifth Affiliated Hospital of Jinan University, Jinan University, Heyuan, China have published the article: Vascular Disruptive Hydrogel Platform for Enhanced Chemotherapy and Anti-Angiogenesis through Alleviation of Immune Surveillance, in the Journal: Pharmaceutics 2022, 1809 of /2022/
- what: This work provides a new treatment strategy through the mediation of the tumor microenvironment by disruption to fulfill enhanced and immunotherapy. The main reasons for the low therapeutic efficacy include the tumor heterogeneity among different patients, and the immune surveillance environment in human bodies, containing immunosuppressive . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.